American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern: blepharitis. October 2013. http://one.aao.org (last accessed 20 February 2017).
McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.
NHS Choices. Blepharitis. May 2010. http://www.nhs.uk/ (last accessed 20 February 2017).
Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.
Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.
1. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern: blepharitis. October 2013. http://one.aao.org (last accessed 20 February 2017).
2. Smith RE, Flowers CW Jr. Chronic blepharitis: a review. CLAO J. 1995;21:200-207.
3. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.
4. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788-793.
5. Stone DU, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol. 2004;15:499-502.
6. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40:343-367.
7. NHS Choices. Blepharitis. May 2010. http://www.nhs.uk/ (last accessed 20 February 2017).
8. IMS America. National disease and therapeutic index. Ambler, PA: IMS America, Ltd., 1984.
9. Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68:524-528.
10. Groden LR, Murphy B, Rodnite J, et al. Lid flora in blepharitis. Cornea. 1991;10:50-53.
11. Thygeson P. Etiology and treatment of blepharitis. Arch Ophthalmol. 1946;36:445-477.
12. Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486-491.
13. McCulley JP, Dougherty M. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc U.K. 1986;105:314-318.
14. Shine WE, Silvany R, McCulley JP. Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci. 1993;34:2291-2296.
15. Allen JH. Staphylococcic conjunctivitis. Am J Ophthalmol. 1937;20:1025-1031.
16. Thygeson P. Bacterial factors in chronic catarrhal conjunctivitis. Arch Ophthalmol. 1937;18:373-387.
17. Seal D, Ficker L, Ramakrishnan M, et al. Role of staphylococcal toxin production in blepharitis. Ophthalmology. 1990;92:1684-1688.
18. Mondino BJ, Caster AI, Dethlefs B. A rabbit model of staphylococcal blepharitis. Arch Ophthalmol. 1987;105:409-412.
19. Ficker L, Ramakrishnan M, Seal D, et al. Role of cell-mediated immunity to staphylococci in blepharitis. Am J Ophthalmol. 1991;111:473-479.
20. Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.
21. Jester JV, Nicolaides N, Smith RE. Meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1989;30:927-935.
22. Dougherty JM, McCulley JP. Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:52-56.
23. Shine WE, McCulley JP. The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci. 1991;32:2272-2280.
24. Shine WE, McCulley JP. Meibomianitis: polar lipid abnormalities. Cornea. 2004;23:781-783.
25. Akpek EK, Polcharoen W, Chan R, et al. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea. 1999;18:282-288.
26. Brownstein B, Codere F, Jackson WB. Masquerade syndrome. Ophthalmology. 1980;87:259.
27. Gao YY, Di Pascuale M, Li W, et al. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005;46:3089-3094.
28. Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J. 1996;22:209-212.
29. Bowman RW, Dougherty JM, McCulley JP. Chronic blepharitis and dry eyes. Int Ophthalmol Clin. 1987;27:27-35.
30. Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25:171-175.
31. Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.
32. O'Gallagher M, Bunce C, Hingorani M et al. Topical treatment for blepharokeratoconjunctivitis (BKC) in children. Cochrane Database Syst Rev 2017;2:CD011965.
33. Smolin G, Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol. 1977;95:812-816.
34. Opitz DL, Tyler KF. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin Exp Optom. 2011;94:200-206.
35. Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther. 2008;25:858-870.
36. Haque RM, Torkildsen GL, Brubaker K, et al. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea. 2010;29:871-877.
37. Lamberts DW, Buka T, Knowlton GM. Clinical evaluation of trimethoprim-containing ophthalmic solutions in humans. Am J Ophthalmol. 1984;98:11-16.
38. Miller IM, Vogel R, Cook TJ, et al. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. Am J Ophthalmol. 1992;113:638-644.
39. Bloom PA, Leeming JP, Power W, et al. Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis. Eur J Ophthalmol. 1994;4:6-12.
40. Dursun K, Kim MC, Solomon A, et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline, and corticosteroids. Am J Ophthalmol. 2001;132:8-13.
41. Gao YY, Di Pascuale MA, Elizondo A, et al. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea. 2007;26:136-143.
42. Dougherty JM, McCulley JP, Silvany RE, et al. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991;32:2970-2975.
43. Cullen SI, Crounse RG. Cutaneous pharmacology of the tetracyclines. J Invest Derm. 1965;45:263-268.
44. Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14:144-146.
45. Gruber GC, Callen JP. Systemic complications of commonly used dermatologic drugs. Cutis. 1978;21:825-829.
46. Ta CN, Shine WE, McCulley JP, et al. Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis. Cornea. 2003;22:545-548.
47. Shine WE, McCulley JP, Pandya AG. Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res. 2003 Apr;76(4):417-20.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台